Genexine has ranked among the top searched stocks for 7 days in the past month.
As of 12:30 PM on the 4th, Genexine is trading at 99,700 KRW, down 2.64% from the previous day. This represents a 7.08% decrease compared to February 18. Genexine is known as a company specializing in the development of biopharmaceuticals.
Today, foreigners are tentatively recorded as net sellers of 7,000 shares. Over the past 5 days, individual investors have net sold 29,931 shares, while foreigners and institutions have net bought 51,785 shares and net sold 37,845 shares, respectively.
On March 2, Genexine was an issue in the market with the headline "Strong performance on news of COVID-19 vaccine clinical trials."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
